Table 4.
Overall efficacy evaluation of patients in each group during the follow-up period (7th weekend).
Group | Significant effect | Effective | Invalid | Efficient (%) |
---|---|---|---|---|
A | 3 | 28 | 2 | 93.94 |
B | 2 | 28 | 3 | 90.91 |
C | 1 | 25 | 7 | 78.79 |
Overall efficacy evaluation of patients in each group during the follow-up period (7th weekend).
Group | Significant effect | Effective | Invalid | Efficient (%) |
---|---|---|---|---|
A | 3 | 28 | 2 | 93.94 |
B | 2 | 28 | 3 | 90.91 |
C | 1 | 25 | 7 | 78.79 |